1. The Role of Coronary Artery Calcium Testing for Value-Based Clinical Trials in Primary Prevention

   • Emilio Fentanes
   • Miguel Cainzos Achirica
   • Ron Blankstein

   Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor) 15 September 2021 Article: 73

   

2. Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis

   • Patricia Hernandez
   • Neena Passi
   • Daniel Soffer

   Cardiovascular Disease and Stroke (J. A. Underberg and J. Newman, Section Editors) 13 September 2021 Article: 72

   

3. Lipid Phenotypes and DNA Methylation: a Review of the Literature

   • Alana C. Jones
   • Marguerite R. Irvin
   • Donna K. Arnett

   Genetics and Genomics (A. Marian, Section Editor) 01 September 2021 Article: 71

   

4. Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease

   • Paniz Vafaei
   • Sahar Naderi
   • Justin J. Slade

   Coronary Heart Disease (S. Virani and S. Naderi, Section Editors) 01 September 2021 Article: 70

5. RNA Silencing in the Management of Dyslipidemias

   • Neil C. Henney
   • Maciej Banach
   • Peter E. Penson

   Nonstatin Drugs (M. Vrablik, Section Editor) Open access 01 September 2021 Article: 69

   

6. Phytosterols and Cardiovascular Disease

   • Umidakhon Makhmudova
   • P. Christian Schulze
   • Oliver Weingärtner

   Cardiovascular Disease and Stroke (J. A. Underberg and J. Newman, Section Editors) Open access 01 September 2021 Article: 68

   

7. Psoriasis and Cardiovascular Disease: Novel Mechanisms and Evolving Therapeutics

   • Brittany Weber
   • Joseph F. Merola
   • Michael S. Garshick

   Cardiovascular Disease and Stroke (J. A. Underberg and J. Newman, Section Editors) 01 September 2021 Article: 67

8. Clonal Hematopoiesis of Indeterminate Potential: an Expanding Genetic Cause of Cardiovascular Disease

   • Romit Bhattacharya
   • Alexander G. Bick

   Genetics and Genomics (A. Marian, Section Editor) 01 September 2021 Article: 66

   

9. Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)

   • Laura D’Erasmo
   • Simone Bini
   • Marcello Arca

   Nonstatin Drugs (M. Vrablik, Section Editor) Open access 01 September 2021 Article: 65